Chicago Capital LLC lowered its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 0.6% during the second quarter, HoldingsChannel.com reports. The firm owned 179,422 shares of the medical research company’s stock after selling 997 shares during the period. Chicago Capital LLC’s holdings in Edwards Lifesciences were worth $16,925,000 at the end […]
Edwards Lifesciences (NYSE: EW ) has outperformed the market over the past 15 years by 10.11% on an annualized basis producing an average annual return of 19.59%. Currently, Edwards Lifesciences has a market capitalization of $42.33 billion. Buying $100 In EW: If … Full story available on Benzinga.com
Wednesday''s top analyst upgrades and downgrades included AMC Entertainment, Bumble, Comerica, Dell Technologies, Edwards Lifesciences, Etsy, Fisker, Luminar Technologies, Micron Technology, Opendoor Technologies, Pinterest and Snap.
Edwards Lifesciences was the subject of an EU antitrust probe last week on concerns of market abuse. Read more here.
… $109,000. Several other large investors have also recently modified their … . Hedge funds and other institutional investors own 79.25% of the … $92.42. Want More Great Investing Ideas? Check Out Our Latest …
Park Avenue Securities LLC lessened its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 4.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 45,563 shares of the medical research company’s stock after selling 2,029 shares during the quarter. Park […]
On September 17, 2023, Edwards Lifesciences (NYSE:EW) received a downgrade from analysts at StockNews.com. The research report downgraded the company’s rating from “buy” to “hold”. As a result of this downgrade, shares of EW stock traded down $0.82 during mid-day trading on Friday, reaching $73.20. Edwards Lifesciences has a trading volume of 3,985,637 shares, which […] The post Edwards Lifesciences Receives Downgrade from StockNews.com Analysts appeared first on Best Stocks .
Edwards Lifesciences (NYSE: EW ) has outperformed the market over the past 15 years by 10.72% on an annualized basis producing an average annual return of 19.75%. Currently, Edwards Lifesciences has a market capitalization of $44.69 billion. Buying $1000 In EW: If … Full story available on Benzinga.com
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW ) used to be "one of the greatest stocks of our time and, it’s now just terrible." When asked about CVS Health Corporation (NYSE: CVS ), he said, "I think that this thing between the price of say 60 and 70 is going to bottom. It’s got all the problems that we know about, every company that has a theft issue, that’s what’s really hurting it now." Cramer said he used to love International Flavors & Fragrances … Full story available on Benzinga.com